Document Details
Form
Filing Date
May 31, 2019
Document Date
May 29, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
ASELAGE STEVE